Cutting-Edge Insights in Myeloma, Lymphoma, and Leukemia: Post ASH Virtual CME

MSK's Physician Relations Team invites you to a complimentary one-hour, virtual update on the latest developments in myeloma, leukemia, and lymphoma. This complimentary lecture series, hosted by MSK's Physician Relations Team and led by MSK faculty experts, aims to provide valuable updates and insights across a wide range of topics. This session will provide a thorough review of key highlights and the impact of new data presented at ASH 2023.

Highlights Include:

Myeloma Focus: Dr. Sham Mailankody, Myeloma Medical Oncologist, highlights key advances for myeloma and plasma cell disorders. He explores the implications of new data on the clinical care of patients with myeloma.

Leukemia Updates: Dr. Aaron Goldberg, Leukemia Medical Oncologist shares the latest developments in leukemia care. He will review high-impact data for leukemia, MDS, and MPN, and engage in discussions on selected early-phase clinical trials that will significantly influence patient care.

Lymphoma Insights: Dr. Pallawi Torka, Lymphoma Medical Oncologist explores lymphoid malignancies. She discusses practice-changing data and selected early-phase clinical trials that will shape the care of patients with lymphoma in the next decade.

1. Review key highlights for myeloma & plasma cell disorders from ASH 2023
2. Discuss high impact data for leukemia & early phase clinical trials from ASH 2023
3. Understand practice changing data for lymphoid malignancies & early phase clinical trials from ASH 2023

Registration is complimentary. Please sign up through the 'Register' tab at the top of the page. Detailed access and participation instructions, including a Zoom link, will be sent to you from Zoom upon completion of registration.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). MSK CME is not responsible for any related costs, charges, or expenses to participants.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MSK Course Faculty 

Aaron D. Goldberg, MD, PhD

Sham Mailankody, MBBS

Pallawi Torka, MD

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Friday, March 15, 2024